CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 5. Northern blot analysis of expression of trkA, trkC, and of the neuronal marker genes NPY and GAP-43 in SH-SY5Y/trkC and SY5Y/trkA cells treated with NTs. A, cells were grown for 4 days in serum-free medium alone or in medium supplemented with 100 ng/ml NT-3, 100 ng/ml NGF, or 100 ng/ml NT-3 + 100 ng/ml NGF. Total RNA (15 µg) was analyzed for expression of NPY (0.8 kb), trkA (3.5 kb), and trkC (bars at left, 2.8 and 1.2 kb). B, SH-SY5Y/trkC (3:1) and SY5Y/trkA cells were grown for 4 days in serum-containing medium supplemented with increasing concentrations of NT-3 or NGF. Fifteen µg of total RNA were analyzed for expression of NPY and GAP-43. C, SH-SY5Y/trkC (3:1 and 3:2) and SY5Y/trkA cells were grown for 4 days in serum-containing medium supplemented with 100 ng/ml NT-3 or NGF. In all panels, GAPDH (1.5 kb) mRNA levels were used as a reference for the amount of loaded RNA.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation